The goal of this observational study is to examine the early hemodynamic effects and clinical outcomes of vasopressin use in patients with septic shock. The study aims to compare adult ICU patients who received norepinephrine alone versus those who received vasopressin in addition to norepinephrine. The main question it aims to answer is: Does adding vasopressin to norepinephrine improve blood pressure, lactate levels, and survival in patients with septic shock? Researchers used retrospective medical records of patients treated between January and December 2024. Data such as blood pressure, heart rate, lactate levels, and mortality were collected and analyzed to assess treatment response and outcomes.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Mean Arterial Pressure (MAP) Within 24 Hours After Vasopressin Initiation
Timeframe: 6 hours after vasopressor initiation